Lantheus
LNTH
Collegium Pharmaceutical
COLL
Constellation Brands
STZ
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
US Stock MarketDetailed Quotes
VNDA Vanda Pharmaceuticals
- 4.710
- -0.140-2.89%
Close Mar 10 16:00 ET
- 4.662
- -0.048-1.03%
Post 20:01 ET
274.67MMarket Cap-14.27P/E (TTM)
4.830High4.660Low435.65KVolume4.770Open4.850Pre Close2.06MTurnover0.84%Turnover RatioLossP/E (Static)58.32MShares6.75052wk High0.51P/B243.21MFloat Cap3.71052wk Low--Dividend TTM51.64MShs Float33.440Historical High--Div YieldTTM3.50%Amplitude0.450Historical Low4.719Avg Price1Lot Size
About Vanda Pharmaceuticals Company
Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.
Company Profile
SymbolVNDA
Company NameVanda Pharmaceuticals
Listing DateApr 12, 2006
Issue Price10.00
Founded2002
CEODr. Mihael Hristos Polymeropoulos,M.D.
MarketNASDAQ
Employees368
Fiscal Year Ends12-31
Address2200 Pennsylvania Avenue Northwest,Suite 300 E
CityWashington
ProvinceDistrict of Columbia
CountryUnited States of America
Zip Code20037
Phone1-202-734-3400
Websitehttp://www.vandapharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Mihael Hristos Polymeropoulos,M.D.
- Chairman of the Board, President and Chief Executive Officer
- 3.72M
- Joakim Wijkstrom
- Senior Vice President and Chief Marketing Officer
- 1.36M
- Kevin Moran
- Senior Vice President, Principal Accounting Officer, Chief Financial Officer and Treasurer
- 1.32M
- Gunther Birznieks
- Senior Vice President, Business Development
- 1.37M
- Timothy Williams
- Senior Vice President, General Counsel and Secretary
- 1.40M
- Dr. Stephen Ray Mitchell, M.B.A.,M.D.
- Independent Director
- 282.50K
- Richard W. Dugan
- Lead Independent Director
- 332.50K
- Dr. Tage Honore, D.Sc.,PhD
- Independent Director
- 602.43K
- Phaedra S. Chrousos
- Independent Director
- 300.00K
- Anne Sempowski Ward
- Independent Director
- 302.50K